Boston Scientific Corp

FMR LLC BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

97,386,941

Value ($000)

9,285,845

Weight

0.5%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	9,285,845	0.5%	97,386,941	12/31/2025
2025 Q3	11/13/2025	9,712,008	0.5%	99,477,701	9/30/2025
2025 Q2	8/14/2025	11,633,639	0.7%	108,310,577	6/30/2025
2025 Q1	5/12/2025	12,972,887	0.8%	128,597,214	3/31/2025
2024 Q4	2/13/2025	11,829,798	0.7%	132,442,883	12/31/2024
2024 Q3	11/13/2024	11,329,500	0.7%	135,196,894	9/30/2024
2024 Q2	8/13/2024	10,893,886	0.7%	141,460,666	6/30/2024
2024 Q1	5/13/2024	9,720,787	0.7%	141,930,013	3/31/2024
2023 Q4	2/13/2024	7,992,287	0.6%	138,250,950	12/31/2023
2023 Q3	11/13/2023	6,648,595	0.6%	125,920,357	9/30/2023
2023 Q2	8/11/2023	6,375,864	0.5%	117,875,094	6/30/2023
2023 Q1	5/11/2023	5,691,467	0.5%	113,761,084	3/31/2023
2022 Q4	2/13/2023	4,681,744	0.5%	101,183,146	12/31/2022
2022 Q3	11/10/2022	3,180,786	0.3%	82,127,171	9/30/2022
2022 Q2	8/12/2022	2,905,869	0.3%	77,968,047	6/30/2022
2022 Q1	5/13/2022	4,124,257	0.3%	93,119,379	3/31/2022
2021 Q4	2/14/2022	4,201,523	0.3%	98,905,912	12/31/2021
2021 Q3	2/14/2022	4,668,702	0.4%	107,598,578	9/30/2021
2021 Q2	8/13/2021	4,417,338	0.3%	103,305,355	6/30/2021
2021 Q1	5/14/2021	3,333,605	0.3%	86,251,101	3/31/2021
2020 Q4	2/8/2021	2,323,758	0.2%	64,638,630	12/31/2020
2020 Q3	11/13/2020	2,358,422	0.2%	61,722,644	9/30/2020
2020 Q2	8/24/2020	2,385,227	0.3%	67,935,795	6/30/2020
2020 Q1	5/14/2020	3,359,044	0.5%	102,943,438	3/31/2020
2019 Q4	2/7/2020	5,766,206	0.6%	127,514,509	12/31/2019
2014 Q1	5/15/2014	2,676,998	0.4%	198,002,793	3/31/2014
2013 Q4	2/13/2014	2,163,126	0.3%	179,960,532	12/31/2013